| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |